Loading clinical trials...
Loading clinical trials...
Reduction in size and number of oral premalignant lesions
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT02158858 · Myelofibrosis, Leukemia, Myelocytic, Acute, and more
NCT01752114 · Precancerous Conditions, Carcinoma
NCT00043615 · Neoplasms, Precancerous Conditions
NCT01752101 · Precancerous Conditions, Carcinoma
NCT00314262 · Precancerous Conditions
Pfizer Investigational Site
Farmington, Connecticut
Pfizer Investigational Site
Shreveport, Louisiana
Pfizer Investigational Site
Ann Arbor, Michigan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions